Catheter Precision
VTAK
16 hedge funds and large institutions have $257K invested in Catheter Precision in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 6 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
20% less funds holding
Funds holding: 20 → 16 (-4)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
39% less capital invested
Capital invested by funds: $420K → $257K (-$163K)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APP
Avantax Planning Partners
Dubuque,
Iowa
|
+$18.5K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.4K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.18K |
| 4 |
SG
StoneX Group
New York
|
+$3.09K |
| 5 |
WAP
Wealthcare Advisory Partners
West Chester,
Pennsylvania
|
+$3.09K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$40.2K |
| 2 |
Citigroup
New York
|
-$15.5K |
| 3 |
Two Sigma Investments
New York
|
-$15.5K |
| 4 |
Bank of New York Mellon
New York
|
-$11K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9.27K |
VTAK Hedge Fund Activity: Q2 2022 in Review
16 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q2 2022, worth a combined $257K — down 39% from $420K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of VTAK and 3 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Avantax Planning Partners, adding an estimated $18.5K. The largest seller was Virtu Financial, cutting an estimated $40.2K.
- 16 institutional investors held Catheter Precision (VTAK) as of Q2 2022, down from 20 in Q1 2022.
- Funds reported $257K of Catheter Precision stock for Q2 2022, down 39% quarter-over-quarter.
- 3 funds opened new Catheter Precision positions in Q2 2022 and 6 closed out, a net change of -3 holders.
- The largest Catheter Precision buyer in Q2 2022 was Avantax Planning Partners, an estimated $18.5K added.
- The largest Catheter Precision seller in Q2 2022 was Virtu Financial, an estimated $40.2K sold.
Based on aggregated 13F filings for Q2 2022.